Disease and Development Revisited 1 Acemoglu and Johnson (2007) present evidence that improvements in population health do not promote economic growth. We show that their result depends critically on the assumption that initial health has no causal effect on subsequent economic growth. We argue that such an effect is likely, primarily because childhood health affects adult productivity. In our augmented model, which includes initial health, the instrumental variable proposed by Acemoglu and Johnson has no significant predictive power for improvements in health and does not identify the effect of contemporaneous improvements in health on economic growth.
Introduction
In a recent paper, Acemoglu and Johnson (2007) present empirical results indicating that improvements in population health may have lowered the pace of economic growth. These results contradict much of the preceding literature reviewed in Weil (2007) as well as Bloom, Canning, and Sevilla (2004) , which generally finds that countries with better population health experience faster economic growth. The rationale for Acemoglu and Johnson's view is that while health improvements may increase human capital and worker productivity, lower mortality may increase population size and thereby reduce other factor inputs on a per capita basis.
Acemoglu and Johnson's main argument builds on the observation that improvements in health and economic growth are negatively correlated over the period . We argue that this is not because improvements in health have a deleterious effect on economic growth, but rather because countries that were healthier in 1940 experienced faster subsequent economic growth. Since countries with higher life expectancy in 1940 also experienced less rapid health gains between 1940 and 2000, we observe that health improvements and economic growth are negatively correlated over the same period.
Acemoglu and Johnson show that the negative relationship between improvements in health and economic growth persists even when they instrument health improvements. The instrument they use, mortality from a set of selected diseases in 1940, is a subset of total mortality in 1940, and thus highly correlated with initial life expectancy. In response to an earlier version of this paper (Bloom, Canning and Fink 2009 ), Acemoglu and Johnson acknowledge this correlation, but defend the appropriateness of excluding initial health from their economic growth specification (Acemoglu and Johnson 2009) . The key issue therefore is whether it is 4 plausible that initial life expectancy can be excluded from the growth regression on a priori grounds.
Conditional convergence models of economic growth (Barro and Sala-i-Martin 2004; Durlauf, Johnson and Temple 2005) are based on the idea that income adjusts slowly to its steady state, which suggests substantial lags between changes in fundamentals and economic growth. A particular justification of slow adjustment to steady state in the case of health is that health human capital is constructed in childhood and has economic benefits only when these children become adults.
Health in this cross-country study is measured by life expectancy. While life expectancy depends on age-specific mortality at all ages, the wide gaps in life expectancy in the sample are predominantly due to differences in infant and child mortality. Mortality improvements at older ages only play a major role in life expectancy increases when infant mortality is low and life expectancy is already quite high (Vaupel 1986; de Castro 2001) .
Reductions in infant mortality rates are unlikely to promote worker productivity in the short run. However reductions in infant mortality are correlated with improvements in child health and physical development in the form of adult height (Crimmins and Finch 2006; Akachi and Canning 2007) . Microeconomic studies suggest that early childhood health affects physical and cognitive development, educational outcomes, and productivity when the cohort reaches working age (Barker 1992; Bleakley 2003; Behrman and Rosenzweig 2004; Kremer and Miguel 2004; Case, Fertig and Paxson 2005; Heckman 2007; Hoddinott, Maluccio, Behrman, Flores et al. 2008; Bleakley 2010; Baird, Hicks, Kremer and Miguel 2011) . The health human capital of current workers may therefore reflect their childhood health, as measured by infant and child 5 mortality rates and life expectancy many decades prior, creating a long lag between health improvements and productivity gains.
While we think slow adjustment to steady state when health improves due to the delayed economic benefits from improvements in childhood health is plausible, any model that incorporates an effect of initial health on subsequent economic growth will have similar results to ours. For example, endogenous growth models in the tradition of Nelson and Phelps (1966) , which include health human capital as a driver of technological change, will yield similar results to our model 2 (Aghion, Howitt and Murtin 2011) .
If initial life expectancy matters for economic growth, and the Acemoglu and Johnson instrument is correlated with this omitted variable, their estimates are likely to be inconsistent.
Assuming the response of income to life expectancy follows a partial adjustment process, we
show that both levels and improvements in life expectancy have a significant and positive effect on economic growth in a simple OLS framework. Once we control for initial life expectancy, the Acemoglu and Johnson instrument has almost no predictive power for improvements in life expectancy, so that it cannot be used to identify the causal effect of changes in health on economic growth.
The Acemoglu and Johnson model essentially estimates a bivariate relationship between improvements in life expectancy and economic growth. The exclusion of all other growth determinants would be reasonable if their instrument, changes in predicted mortality, had the properties of a controlled trial, randomly allocating health improvements to countries. However, their instrument is not random, but essentially a measure of national health in 1940. If initial health has a direct causal effect on economic growth as we argue above, the instrument is clearly 6 invalid. Even if initial health does not have a causal effect on economic growth, but is correlated with any actual determinant of economic growth, the instrument will in all likelihood also be correlated with that growth determinant, so the resulting instrumental variable estimates will be inconsistent.
Acemoglu and Johnson report an extensive set of robustness checks to defend the validity of their instrument. They go to great lengths to demonstrate that the instrument is predictive of improvements in life expectancy post-1940, while it is not predictive of changes in health or income between 1900 and 1940. Even though these tests provide strong support for the timing and impact of the analyzed health innovations, they do not address the fundamental omitted variable concern raised in this paper. While the original Acemoglu and Johnson article does
show their results are robust to including initial income and a measure of institutional quality, we
show that their results are not robust to including initial life expectancy.
Empirical Results
We begin by examining the 47 data points used in Acemoglu and Johnson's main regressions.
The data were provided by the authors and are as described in their original paper (Acemoglu and Johnson 2007) . The key variables are log GDP per capita, log life expectancy, and predicted mortality. Predicted mortality is total number of deaths per 100 people in 1940 that are attributable to the 15 diseases that were subject to significant advances in prevention or treatment after 1940. After 1960, predicted mortality is coded as zero for all countries. The Acemoglu and
Johnson instrument for the change in life expectancy between 1940 and 2000 is the change in predicted mortality over the period, which equals the negative of predicted mortality in 1940. Figure 1) . Also notable are the strong and statistically significant positive correlations between the log of initial life expectancy and both the log of initial income per capita and the subsequent growth in income per capita (correlations of 0.81 and 0.5, respectively).
The empirical model used by Acemoglu and Johnson is a basic difference-in-differences model, where the change in log GDP per capita ( y ∆ ) in country i at time t is given by
where x ∆ is the change in log life expectancy, t α is a period-specific constant, and it ε is the error term. Since both life expectancy and GDP per capita are in logs, the differences it y ∆ and it x ∆ can be interpreted as growth rates. We follow Acemoglu and Johnson and assume a linear relation between changes in log income and changes in log life expectancy. This assumption has been challenged by Cervellati and Sunde (2011) 
As discussed in Bloom, Canning, and Sevilla (2004) , this specification is the same as the more general dynamic model given by equation (2) but imposes the common factor restriction γ λβ = . Equation (3) is an error correction model in which income adjusts slowly towards its steady-state value. The Acemoglu and Johnson specification is a special case of this model in which 0, λ = which also implies that 0 γ = . While λ can be expected to be small over short time intervals, our view is that over long time intervals λ should approach unity as all of the initial disequilibrium is corrected. Table 2 reports regression results using the 47-country Acemoglu and Johnson data set.
The dependent variable in all regressions is growth in per capita income during 1940-2000. In column 1 of Table 2 we replicate the Acemoglu and Johnson results, regressing changes in income per capita on changes in log life expectancy using ordinary least squares (OLS). The point estimate of -1.14 (statistically significant at the 99% level) implies that a 10% increase in life expectancy leads to an 11.4% decrease in GDP per capita. In column 2 of Table 2, we replicate another key Acemoglu and Johnson result by instrumenting the change in log life expectancy with the predicted mortality change (this is just the negative of predicted mortality in 1940 since predicted mortality in 2000 is taken to be zero). These estimates suggest that the effect of growth in life expectancy on income growth is negative (a coefficient of -1.51) and statistically significant.
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In column 3 of Table 2 , we include initial log life expectancy along with the growth rate in life expectancy as predictors of economic growth in a simple OLS regression 4 . This reverses the sign of the estimated coefficient on the growth in life expectancy, suggesting a positive effect of the growth in life expectancy on economic growth. However this regression may be subject to bias due to reverse causality from economic growth to the growth in life expectancy or other omitted variables. We refit this regression in column 4 of Table 2 Table WA5 .
In column 5 we add initial log income per capita to the model in order to estimate the parameters of the empirical model given by equation (2). While we find a negative coefficient between zero and unity on initial GDP -as is standard in the literature on conditional convergence -the inclusion of initial GDP increases the estimated effect of both initial health and health improvements on economic growth. We also fit this model using the change in predicted mortality as an instrument for the improvement in life expectancy. The results are reported in column 6 of Table 2 . Once again, the instrument is too weak in the first stage to give precise estimates of the effect of improvements in life expectancy. Given that the instruments are weak, the conventional standard errors for the IV regressions in columns (2), (4) and (6) may be 10 unreliable; we therefore also give 80% confidence intervals for the coefficient on the endogenous variable, the growth in life expectancy, that are robust to weak instruments (see web appendix for details). In columns (4) and (6) the instrument is so weak that these confidence intervals are unbounded.
In column 7 of Table 2 we report a reduced-form estimate of the model in column (6) in which we replace the growth in life expectancy with predicted mortality in 1940. Conditional on initial income and health, predicted mortality in 1940 has no significant effect on economic growth. Given that predicted mortality is not predictive of subsequent improvements in health conditional on initial health, this is perhaps not surprising.
All estimates reported in columns (5) through (8) of Table 2 are based on the assumption that both initial health and changes in health matter for economic growth. Given that actual and predicted changes in life expectancy may be correlated with other omitted determinants of growth even after controlling for initial health and income, our models do not conclusively demonstrate the causal effect of improvements in health on economic growth. Our results do, however, show how sensitive the Acemoglu and Johnson results are to the model specification in general, and to the inclusion of initial life expectancy in particular.
Conclusion
Acemoglu and 
